Effect of beta-blocking drug propranolol on  131 I utilization in euthyroid patients.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001798:Blood Proteins / Q000032:analysis; D002986:Clinical Trials as Topic; D006801:Humans; D007455:Iodine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D007456:Iodine Isotopes; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology*; D011485:Protein Binding; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D001798:Blood Proteins; D007456:Iodine Isotopes; D007455:Iodine; D011433:Propranolol